F01 in the Treatment of Autoimmune Diseases
This study tests a new treatment called F01 for autoimmune diseases, which are conditions where the immune system attacks the body. Examples are lupus, vasculitis, and systemic sclerosis. The study has two parts: dose escalation, where doses are gradually increased to find the safest amount, and dose extension, where the best dose is tested on more people. Participants must be aged between 18 and 65, with specific health criteria depending on their condition. Those with severe lung or heart disease, or other autoimmune diseases, cannot join.
- Study Duration: Participants will be involved in two stages, but specific time frames are not mentioned.
- Eligibility: Open to individuals aged 18-65 with specific autoimmune conditions.
- Risks and Requirements: Participants must have stable health and use effective birth control. Those with severe health issues may not qualify.
Participants will aid in understanding F01's safety and effectiveness in treating autoimmune diseases. 🧬
Study details
NCT06208280
RenJi Hospital
24 January 2024
Not finding the right Trial?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
FAQs
Learn more about clinical trials
What is a clinical trial?
Why should I take part in a clinical trial?
How long does a clinical trial take place?
Do I get compensated for taking part in clinical trials?
How safe are clinical trials?
Study Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.